Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Ailurus Bio is not a typical enterprise SaaS product, but a product and services platform for synthetic biology and life sciences R&D. Its core proposition is to encode complex experimental steps into biological systems through “bioprograms,” allowing cells to take on part of the automation workload. Its clearest current product is PandaPure™ Protein Systems, designed for E. coli protein expression, column-free purification, and tag removal. It also offers the Ailurus vec™ expression library, custom DNA construct design, and supporting documentation.
PandaPure’s key differentiator is the use of synthetic organelles for bioseparation, reducing reliance on traditional resin columns, magnetic beads, and external proteases, while combining target protein purification and tag removal into a simplified workflow. The March 2026 version introduces tag options such as Classic, Hi-affinity, and IEX, and standardizes vector naming including pTEAR, pPEV, and pPEX. Ailurus vec emphasizes screening 1,000 vectors in a single run, supporting protein production optimization and structured data accumulation. Its Design & Construct service covers sequence submission, experimental design, codon optimization, synthesis, cloning, sequencing verification, and shipping.
No specific pricing is disclosed in the text. The terms indicate that catalog products and services are sold at prices published on the website, while custom services require submitting requirements to obtain a Quote, which is typically valid for 30 days. Online checkout requires immediate payment; purchase-order or contract-based purchases default to payment within 30 days after invoicing. For projects involving DNA synthesis, cloning, reagent procurement, and similar work, partial or full prepayment may be required. Prices exclude taxes, shipping, and customs duties.
The main advantage is its highly focused positioning: it offers an integrated path of vectors, reagents, construct services, and documentation around the bottleneck of protein purification. The Standard Edition also includes free construct support for one target protein, which helps reduce friction for first-time users. The drawbacks are that public information on pricing, delivery timelines, applicability boundaries, and validation data is limited in the main materials. Its capabilities are primarily centered on E. coli protein purification, so it should not be treated as a general-purpose automation platform. SaaS-style capabilities such as APIs, permission management, and third-party software integrations are also not disclosed.
It is best suited for synthetic biology labs, protein expression and purification teams, wet-lab validation teams following AI protein design, and researchers looking to reduce dependence on column chromatography. Its accessibility from China cannot be determined from the text. Even if the website is reachable, biological materials, DNA constructs, and reagent procurement may still be affected by cross-border logistics, customs, payment, and local regulations. If procurement is difficult, users can consider local DNA synthesis, vector construction, and protein expression/purification service providers, or continue using traditional options such as Cytiva ÄKTA, affinity chromatography resins, and magnetic beads.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on ailurus.bio official site.
ailurus.bio is an United States Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach ailurus.bio directly.